Your Space
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Diseases > Hereditary Hemochromatosis - It Can Be Treated

Tags

  • through
  • early
  • product
  • early diagnosis
  • combination products

  • Links

  • The Plague of Language - Dispatx Art Collective Summer 2006
  • 5 Specific Questions Your Sales Letters Must Answer To Achieve The Best Results
  • Wrist Arthritis - What Could it Be?
  • Your Space - Hereditary Hemochromatosis - It Can Be Treated

    Hereditary Hemochromatosis (HH) is the most common genetic disorder of persons of northern European extraction. The most common gene involved in causing Hereditary Hemochroma
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    tosis (HH) is the HFE gene. Most patients with hemochromatosis have two copies of the HFE mutation C282Y.

    In persons of northern European extraction approximately 1 in 10 p
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ersons carries one copy of C282Y. Even one copy of C282Y can be associated with too much iron in the liver, high cholesterol, diabetes and the skin disorder porphyria cutanea
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    tarda.

    Approximately 1 in 200 to 300 persons of northern European extraction carry two copies of C282Y. In some northern European populations eg Ireland, Iceland and Bri
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ttany the percentage of persons carrying one copy of C282Y is higher. Predictably countries settled by northern Europeans eg Australia, South Africa and Canada have high rat
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    es of hemochromatosis.

    HH is characterized by excessive absorption of dietary iron and a consequent progressive increase in total body iron stores. Iron accumulates in the
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    parenchymal cells of the liver, the heart, pancreas, anterior pituitary and skin. This accumulation of iron in body tissues causes disease.

    In severe HH the disorder manife
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ts as potentially life threatening conditions such as septicaemia, cirrhosis of the liver, liver cancer, diabetes, heart failure and heart arrhythmias. Arthritis is common a
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    nd a severe arthritis involving numerous joints may occur. Ovarian and testicular failure secondary to iron deposition in the anterior pituitary and possibly the hypothalamu
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    s may occur. Rarely hypothyroidism may occur.

    If HH is not treated liver disease may be fatal. The morbidity and mortality of HH can be reduced by early diagnosis and trea
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    tment by phlebotomy or blood letting.

    There is frequently a delay between the onset of symptoms and diagnosis. This is because early symptoms such as fatigue and arthralgia
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    are non-specific.

    Hereditary Hemochromatosis fits the criteria set by the World Health Organization for population screening for a disease:

    1. The homozygous genotype is c
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    ommon and is potentially fatal if not treated

    2. The disease has a lengthy latent period with asymptomatic iron accumulation followed by a period of iron overload with rever
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    sible organ injury

    3. Treatment during the latent period and the period with reversible organ injury restores the life expectancy to normal. (Treatment is safe, effective a
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    d cost effective)

    4. HH can be detected by measurement of the transferrin saturation (TS).

    It is very important to make an early diagnosis of HH because patients who have n
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ot developed cirrhosis and are treated by phlebotomy have a normal life expectancy.

    When the diagnosis of hemochromatosis is made it is important to adjust the diet so that
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    too much iron is not being absorbed because of an improper diet. The biggest considerations are not to take medications which contain iron, consume too much alcohol or Vitami
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    n C.

    The ingestion of black tea has been shown to decrease the absorption of iron. African tea which is becoming popular may contain iron so too much should not be consumed
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    . Don’t take milk thistle which has often been touted as good for the liver as it can cause severe problems in those with hemochromatosis. Don’t eat raw shellfish. They may
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    be contaminated with Vibrio vulnificans which thrives in an iron rich environment. There have been fatalities in the northern hemisphere. Cooking inactivates this organism


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.yourspace.org.ua/article/242455/yourspace-Hereditary-Hemochromatosis--It-Can-Be-Treated.html">Hereditary Hemochromatosis - It Can Be Treated</a>

    BB link (for phorums):
    [url=http://www.yourspace.org.ua/article/242455/yourspace-Hereditary-Hemochromatosis--It-Can-Be-Treated.html]Hereditary Hemochromatosis - It Can Be Treated[/url]

    Related Articles:

    Search Engine Optimization: Hire a SEO Company or Do It Yourself

    Can We Change Our Core Personality?

    How To Defeat Diabetes Even If You Have A Sweet Tooth

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com